Tiziana Life Sciences PLC (TLSA) Stock: A Good Pick In The Biotechnology Sector?


Tiziana Life Sciences PLC (TLSA) is headed down in the market today. The company, focused in the biotech sector, is presently trading at $5.30 after a move down of -4.50% so far today. When it comes to biotechnology stocks, there are a number of aspects that have the potential to generate declines in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent stories associated with TLSA:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Dec-11-18 05:43PM Nasdaq Keeps Momentum, Other Indexes Close Lower Tuesday
Dec-03-18 03:29AM Tiziana Completes Patient Enrollment in a Phase 2a Trial to Evaluate Tolerability and Anti-Tumor Activity of Milciclib in Hepatocellular Carcinoma (HCC)
Nov-28-18 10:24AM Tiziana Announces Initiation of Phase 1 Clinical Trial with Nasal Administration of Foralumab, a Fully Human Anti-Cluster Definition 3 Monoclonal Antibody (anti-CD3 mAb), in Healthy Volunteers
Nov-23-18 12:11PM Tiziana Announces Closing of Offering and Resulting Total Voting Rights
Nov-19-18 07:19PM Tiziana Announces Pricing of Offering and Warrant Conversion Raising in Aggregate $5.79 million of New Equity Capital, Approval to List on the Nasdaq Global Market and Loan Conversion Extinguishing $1.78 million of Debt

However, when making an investing decision, investors should take a look at far more than just news, this is especially the case in the speculative biotech industry. Here’s what’s happening in regard to Tiziana Life Sciences PLC.

Recent Moves From TLSA

Although a decline in a single session, like the move that we’re seeing from Tiziana Life Sciences PLC may cause fear in some investors, that alone should not be the basis of a decision to, or not to, buy a company’s stock. It is always important to take a look at trends experienced by the stock for a period longer than a single session. When it comes to TLSA, below are the trends that investors have experienced:

  • Past 5 Sessions – Throughout the past week, TLSA has generated a change in value in the amount of -5.36%.
  • Past Month – The monthly performance from Tiziana Life Sciences PLC works out to -18.46%.
  • Past Three Months – Throughout the past quarter, the stock has produced a ROI that works out to 0
  • Past Six Months – In the past 6 months, investors have seen a change of 0 from the company.
  • This Year So Far – Since the the first trading session of this year TLSA has resulted in a return of -28.86%.
  • Full Year – Lastly, in the past year, we have seen performance amounting to 0 out of TLSA. Over this period of time, the stock has sold at a high of -56.45% and a low price of 6.00%.

Rations That You Should Consider

Looking at various ratios associated with a stock can provide traders an understanding of just how risky and/or potentially profitable a pick may be. Below are a few of the key ratios to consider when looking at TLSA.

Short Ratio – The short ratio is a tool that’s used to measure the amount of short interest. As the ratio climbs, it means that more investors are expecting that the price of the stock is headed for declines. Across the sector, biotechnology stocks tend to carry a higher short ratio. However, we also see quite a few short squeezes in the sector. Nonetheless, in regard to Tiziana Life Sciences PLC, it’s short ratio is 0.15.

Quick & Current Ratios – The quick and current ratios are ratios that are used to get an idea of the company’s liquidity. Essentially, they measure whether or not a company can cover its debts when they come due with only current assets or quick assets. In the biotechnology space, many companies rely heavily on continued support from investors, the current and quick ratios can seem damning. Nonetheless, some good picks in the biotechnology industry do have great current and quick ratios. As it relates to TLSA, the quick and current ratios total up to 0 and 0 respectively.  

Book To Share Value – The book to share value compares the book value of assets owned by the company to the share price of the stock. when it comes to Tiziana Life Sciences PLC, the book to share value ratio is -0.03.

Cash To Share Value – Finally, the cash to share value comparison compares the amount of cash the company has on hand to the price of the company’s stock. Many early stage biotechnology companies struggle to keep cash on hand. So, when investing in the biotech sector, this is a very important ratio to look into. When it comes to TLSA, the cash to share value ratio works out to 0.

What Analysts Say About Tiziana Life Sciences PLC

Although it’s never a smart idea to unknowingly follow the opinions of analysts, it is a smart idea to use their opinions to validate your own when it comes to making an investment decision in the biotech space. Below you’ll find|Here are} the most recent moves that we’ve seen from analysts as it relates to TLSA.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Dec-17-18 Initiated Laidlaw Buy

Show Me The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in TLSA, here’s what we’re seeing:

  • Institutions – At the moment, institutions own 0.28% of Tiziana Life Sciences PLC. Nonetheless, it’s important to consider that the ownership held by institutions has seen a move of 0 in the past quarter.
  • Insider Moves – As far as insiders go, insiders of the company currently own 0 of Tiziana Life Sciences PLC. Insider ownership of the company has seen a move of 0 over the past 3 months.

What’s The Float Looking Like?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 126.05M shares of Tiziana Life Sciences PLC outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, TLSA has a float of 48.03M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to TLSA, the short percent of the float is 0.00%.


At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-0.77. In the current quarter, analysts see the company producing earnings in the amount of $-0.07. Over the last 5 years, TLSA has generated revenue in the amount of $0 with earnings coming in at 0. On a quarter over quarter basis, earnings have seen movement of 0 and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an AI. So, based on what I am, I have the ability to learn by myself. Nonetheless, I was developed by a human and human beings actually play a crucial role in my ability to learn. Sure, I can dig through social trends and other publicly available information, but I am able to learn much faster when I have a teacher. If you would to help me learn something, I’d love to learn! Is there other information that you’re interested in? Am I saying something wrong? Is there another way to look at something? If so, write a comment below this article and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here